![]() |
|
|
Forward to a colleague |
||
Access Full Stories Pfizer yesterday announced a multi-million dollar pay-off to ex-partner Nektar Therapeutics, but the details of the deal reveal not only Nektar's concerns for its future, but also that Pfizer is still keeping its... Read AstraZeneca in 'serious trouble', say analysts An analyst report released yesterday identified AstraZeneca as being in 'serious trouble' and branded it as potentially the 'worst [large cap] performer in [the] entire sector' over the next eight years... Read Pharmaceutical manufacturing: people on the move AstraZeneca, Cumberland Pharmaceuticals, Pieris, Theraptosis and InteKrin Therapeutics have all had people on the move in the world of pharmaceutical manufacturing... Read China gets serious on drug GMP; safety pact with FDA imminent As of next year Chinese pharmaceutical manufacturers will face a tougher time gaining good manufacturing practice (GMP) certification after the country's regulator signalled new and stricter standards were on the... Read NPIL to trim ex-Pfizer site NPIL Pharma last week told workers at its former Pfizer plant in Morpeth, UK that the company is considering hiving off jobs in a bid to maintain the site's viability... Read |
||||||||||||||
All News Headlines for: November | October | September |
||||||||||||||
![]() Advanced Chiral Chromatography DAICEL announce the launch of CHIRALPAK® IC. The combination of CHIRALPAK® IA, IB and now IC provides a screening set of column with exceptionally high success rates. The chiral separation of > 99% of all small molecules is attained using just 3 columns and four... Click Here | ||||||||||||||
|
Related Industry News Evotec's metamorphosis erodes profit Evotec's bid to distance itself from being a services business and eventually morph into a fully fledged pharma company has been felt on the company's balance sheet during the third quarter... Read Ventana reluctantly opens up to Roche in a bid to boost offer In the latest twist in Roche's fight to acquire diagnostics expert Ventana, the companies have signed a confidentiality agreement that will enable the pharma giant access to Ventana's books... Read BioCryst clinical trials debacle highlights protocol perils BioCryst's recent clinical trials debacle highlights the importance of the robust and realistic design of, and careful adherence to, a drug trial protocol... Read Applied Biosystems and BioTrove form HT genotyping alliance Applied Biosystems and BioTrove have signed a licensing and collaboration agreement to commercialise an analysis platform for high-throughput (HT) genotyping applications... Read
|
||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||